Future Capital

Well-link is a Chinese cloud gaming service provider.

Beijing Yuanbao Technology Co., Ltd. is a technology company founded in 2018 and based in Beijing, China. It specializes in cyber security by offering a range of services including cyber security assessment consulting, network security detection, and cyber security insurance solutions. Yuanbao Tech provides enterprises with risk monitoring and evaluation services aimed at reducing the likelihood of cyber security risks. The company also assists insurance and reinsurance firms by developing models and technical services for cyber security insurance products, as well as conducting risk assessments for their insured clients. Through its integrated solutions, Yuanbao Tech plays a crucial role in enhancing network security management for businesses.

Megarobo Technology Co., Ltd. engages in collaborative robotics research and development. The company provides automation solutions for life science, intelligent retail, and lightweight manufacturing. It offers robot, motion control, and software services. The company also provides facility on lease with technical support service to use robots. Megarobo Technology Co., Ltd. was founded in 2016 and is based in Beijing, China with additional offices in Suzhou, Shenzhen, and Munich, China.

Duckbill is a logistics and transportation company that specializes in container trucking services, international freight forwarding, and warehousing solutions. By leveraging big data and artificial intelligence, Duckbill effectively manages its fleets to enhance operational efficiency and improve worker safety. The company focuses on providing standardized and large-scale transportation services, ensuring reliability and responsiveness in the logistics sector. Through its innovative technology-driven approach, Duckbill aims to streamline the supply chain process and meet the evolving needs of its clients.

Duckbill is a logistics and transportation company that specializes in container trucking services, international freight forwarding, and warehousing solutions. By leveraging big data and artificial intelligence, Duckbill effectively manages its fleets to enhance operational efficiency and improve worker safety. The company focuses on providing standardized and large-scale transportation services, ensuring reliability and responsiveness in the logistics sector. Through its innovative technology-driven approach, Duckbill aims to streamline the supply chain process and meet the evolving needs of its clients.

Aignostics GmbH, founded in 2018 and based in Berlin, Germany, specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics by utilizing its patented technology to provide explainable AI that addresses the limitations of traditional AI systems. Aignostics' platform generates precise heatmaps and image overlays that facilitate the interpretation of diagnostic results, allowing pathologists to quickly verify findings. This capability is essential for ensuring accurate diagnoses, particularly in the context of drug development and the discovery of tissue-based biomarkers for complex diseases like cancer. By improving the understanding of pathology, Aignostics supports more effective diagnoses and treatments in the medical field.

ClickPaaS is a technology company that specializes in developing an artificial intelligence-driven low-code application platform. Founded in 2017 and based in Shanghai, China, ClickPaaS offers a range of services designed to enhance productivity for various enterprises. Its platform supports system construction, data integration, and performance optimization, catering to needs such as enterprise resource planning (ERP), customer relationship management (CRM), supply chain management, and mobile application development. The company primarily serves government agencies, consulting firms, startups, and professional partners, enabling them to efficiently meet complex business requirements while significantly reducing response times and costs. Through its innovative approach, ClickPaaS aims to facilitate industrial transformation and improve overall business productivity for its clients.

Suzhou Ruixun Biotechnology Co., Ltd. specializes in the development of medical equipment focused on molecular diagnostics and gene detection. Founded in 2017 and headquartered in Suzhou, China, the company offers a range of products including digital polymerase chain reaction (PCR) systems, genetic diagnosis devices, and associated reagents. Ruixun Biotech aims to advance healthcare through innovative diagnostic solutions.

Lixiang, formerly known as Chehejia (“Car and Home”), is a Beijing-based electric vehicle startup that plans to disrupt the transportation and auto industries through complete vertical integration. It designs, researches, manufactures, sells, and offers services featuring a few models of electric vehicles. It makes products including smart EVs and electric SUVs to provide customers with longer crosstown journeys. Lixiang also offers rental services and Uber-like on-demand ride-hailing. It was founded in 2015.

Missevan is a domestic leading secondary audio community.

Yihang.ai manufactures autonomous driving systems. Yihang Intelligent provides the host factory with a complete auto-driving solution with high reliability, high quality and low cost. Since its establishment, Yihang Intelligent has been aiming at productization and strictly follows the development process of the main engine factory. At present, Autopilot has been commercialized, and Autopilot function autopilot solution is provided for a certain production model. It is applied to Level 4 deep learning technology research and development. Breakthroughs have also been made to achieve real-time pixel-level image segmentation based on deep learning on a car-level embedded chip. Yihang intelligent team is proficient in artificial intelligence and core algorithms such as sensing, decision-making, control and fault diagnosis. It integrates the elites of the automotive industry and experts in computer vision and deep learning. The team members are from domestic and foreign OEMs, Tier 1 suppliers, domestic and foreign. Leading scientific research institutions and famous universities at home and abroad such as Berkeley and Cambridge.It began operation in 2015, with its headquarters in Beijing in China.

Nanjing Nongfenqi E-Commerce Co., Ltd. is a rural internet finance services platform based in China that specializes in installment financial services for the agricultural sector. The company enables farmers to purchase farm machinery, procure agricultural supplies, and pay land transfer fees through manageable installment payments. Catering primarily to large farming groups and collaborative communes, Nongfenqi has already served approximately 20,000 clients, facilitating easier access to essential agricultural equipment and resources. By providing these financial solutions, Nongfenqi aims to enhance the efficiency and productivity of farmers, ultimately transforming the agricultural landscape.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

Ganymed Pharmaceuticals AG is a biopharmaceutical company with the mission of revolutionizing cancer treatment by developing a new class of therapeutic drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues. They can thus be administered at optimal dose and have a broad therapeutic window with reduced risks of side effects.

3-G International develops software-based smart card, biometric, and card management solutions. The company was founded in 1982 and is headquartered in Springfield, Virginia.